A
Amanda Hanora Lavan
Researcher at Cork University Hospital
Publications - 27
Citations - 825
Amanda Hanora Lavan is an academic researcher from Cork University Hospital. The author has contributed to research in topics: Polypharmacy & Medicine. The author has an hindex of 10, co-authored 21 publications receiving 524 citations. Previous affiliations of Amanda Hanora Lavan include National University of Ireland & University College Cork.
Papers
More filters
Journal ArticleDOI
Predicting risk of adverse drug reactions in older adults
TL;DR: Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation.
Journal ArticleDOI
STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail Adults with Limited Life Expectancy): Consensus Validation
Amanda Hanora Lavan,Amanda Hanora Lavan,Paul Gallagher,Paul Gallagher,Carole Parsons,Denis O'Mahony,Denis O'Mahony +6 more
TL;DR: STOPPFrail comprises 27 criteria relating to medications that are potentially inappropriate in frail older patients with limited life expectancy and may assist physicians in deprescribing medications in these patients.
Journal ArticleDOI
Methods to reduce prescribing errors in elderly patients with multimorbidity.
TL;DR: This review examines the various ways of minimizing prescribing errors in multimorbid older people and published data support focused prescriber education in geriatric pharmacotherapy, routine application of STOPP/START criteria for potentially inappropriate prescribing, electronic prescribing, and close liaison between clinical pharmacists and physicians in relation to structured medication review and reconciliation.
Journal ArticleDOI
Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy : the SENATOR∗ randomized controlled clinical trial
Denis O'Mahony,Adalsteinn Gudmundsson,Roy L. Soiza,Mirko Petrovic,Alfonso J. Cruz-Jentoft,Antonio Cherubini,Richard Fordham,Stephen Byrne,Darren Dahly,Paul Gallagher,Amanda Hanora Lavan,Denis Curtin,Kieran Dalton,Shane Cullinan,Evelyn Flanagan,Frances Shiely,Olafur Samuelsson,Ástrós Sverrisdóttir,Selvarani Subbarayan,Lore Vandaele,Eline Meireson,Beatriz Montero-Errasquín,Aurora Rexach-Cano,Andrea Correa Perez,Isabel Lozano-Montoya,M. Vélez-Díaz-Pallarés,Annarita Cerenzia,Samanta Corradi,Maria Soledad Cotorruelo Ferreiro,Federica Dimitri,Paolo Marinelli,Gaia Martelli,Rebekah Fong Soe Khioe,Joseph A. Eustace +33 more
TL;DR: In this paper, a pragmatic, multi-national, parallel arm prospective randomized open-label, blinded endpoint (PROBE) controlled trial enrolling patients at six European medical centres was conducted, where 1,537 older medical and surgical patients with multi-morbidity and polypharmacy on admission were randomized to SENATOR software-guided medication optimization plus standard care.
Journal ArticleDOI
Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Amanda Hanora Lavan,Amanda Hanora Lavan,Deirdre O'Mahony,Deirdre O'Mahony,Mary Buckley,Denis O'Mahony,Denis O'Mahony,Paul Gallagher,Paul Gallagher +8 more
TL;DR: It is identified that ADRs caused or contributed to one in five hospital admissions of patients with cancer, and more than 21% of admissions to an oncology service are ADR-related.